TABLE 1

Baseline Characteristics of Participants According to Treatment Assignment

VariableII (N = 40)SH (N = 20)P
Age, mean ± SD, y12.3 ± 0.712.5 ± 0.6.21
Gender, % girls47.540.0.78
No. of members in household, mean ± SD4.5 ± 1.04.9 ± 1.4.21
BMI, mean ± SD, kg/m225.4 ± 4.726.7 ± 5.5.37
zBMI, mean ± SD1.6 ± 0.61.7 ± 0.6.39
Height, mean ± SD, cm152.3 ± 7.6152.2 ± 8.0.96
Weight, mean ± SD, kg59.0 ± 11.862.5 ± 16.3.36
Body fat, mean ± SD, %32.6 ± 10.832.6 ± 8.8.99
Average systolic BP, mean ± SD, mm Hg110.9 ± 12.3112.9 ± 18.0.62
Average diastolic BP, mean ± SD, mm Hg68.9 ± 9.367.4 ± 11.2.57
Total cholesterol, mean ± SD, mg/dLa164.30 ± 25.70163.45 ± 32.75.93
LDL cholesterol, mean ± SD, mg/dLa99.84 ± 23.57101.29 ± 28.54.87
HDL cholesterol, mean ± SD, mg/dLa45.45 ± 9.4741.64 ± 8.55.25
Triglycerides, mean ± SD, mg/dLa88.86 ± 38.24102.64 ± 52.86.37
Glucose, mean ± SD, mmol/La4.34 ± 0.554.50 ± 0.17.18
Insulin, mean ± SD, μIU/mLa27.86 ± 21.8431.72 ± 19.71.62
  • Because these measurements were not required to participate in the study, the number size differs for blood biomarkers.

  • a II: N = 29; SH: N = 9.